The tumor-associated glyco-code correlates with the heterogeneous expression patterns of Tn, STn, and ST and other TACA ligands on glycoproteins and glycolipids of cancer cells and their association with patient prognosis and binding to carbohydrate-binding receptors (i.e., lectins) on the cells of the innate and adaptive immune responses (Table 1) (60, 88). Here, EEF1A2 is linked to neoplasm.